These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35448980)
1. Modular and mechanistic changes across stages of colorectal cancer. Rahiminejad S; Maurya MR; Mukund K; Subramaniam S BMC Cancer; 2022 Apr; 22(1):436. PubMed ID: 35448980 [TBL] [Abstract][Full Text] [Related]
2. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules. Wu D; Li Q; Song G; Lu J J BUON; 2016; 21(2):366-74. PubMed ID: 27273946 [TBL] [Abstract][Full Text] [Related]
3. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling. Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987 [TBL] [Abstract][Full Text] [Related]
4. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411 [TBL] [Abstract][Full Text] [Related]
5. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454 [TBL] [Abstract][Full Text] [Related]
6. The identification of a common different gene expression signature in patients with colorectal cancer. Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244 [TBL] [Abstract][Full Text] [Related]
7. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
8. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer. Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326 [TBL] [Abstract][Full Text] [Related]
9. An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer. Samadi P; Soleimani M; Nouri F; Rahbarizadeh F; Najafi R; Jalali A BMC Cancer; 2022 Jul; 22(1):835. PubMed ID: 35907803 [TBL] [Abstract][Full Text] [Related]
10. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
11. Integrative network analysis of transcriptomics data reveals potential prognostic biomarkers for colorectal cancer. Mahajan M; Sarkar A; Mondal S Cancer Med; 2024 Jun; 13(11):e7391. PubMed ID: 38872418 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer. Qi Y; Qi H; Liu Z; He P; Li B J Comput Biol; 2019 Apr; 26(4):364-375. PubMed ID: 30810359 [TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis. Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502 [TBL] [Abstract][Full Text] [Related]
14. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis. Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282 [TBL] [Abstract][Full Text] [Related]
15. RRP9 and DDX21 as new biomarkers of colorectal cancer. Chi X; Yang N; Liu Y Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456 [TBL] [Abstract][Full Text] [Related]
16. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer. Gao X; Yang J DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181 [TBL] [Abstract][Full Text] [Related]
17. Screening of hub genes and pathways in colorectal cancer with microarray technology. Wang Y; Zheng T Pathol Oncol Res; 2014 Jul; 20(3):611-8. PubMed ID: 24504536 [TBL] [Abstract][Full Text] [Related]
18. Construction of an miRNA-mRNA regulatory network in colorectal cancer with bioinformatics methods. Su Y; Zhang M; Zhang L; Chen S; Zhang D; Zhang X Anticancer Drugs; 2019 Jul; 30(6):588-595. PubMed ID: 30601194 [TBL] [Abstract][Full Text] [Related]
19. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis. Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105 [TBL] [Abstract][Full Text] [Related]
20. An age stratified analysis of the biomarkers in patients with colorectal cancer. Yao H; Li C; Tan X Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]